TheEdgeResearch
Home / Stocks / SFLM

SFLMaven Corp. (SFLM)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$223,871
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.21
52-Wk Range
0.0001-0.0001
CEO
Chad MacKay
Country
US
Currency
USD

SFLMaven Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Draper, UT, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $223,871. On trailing twelve-month figures it carries a trailing P/E of -19.25, a net margin of 0.0%. Its beta of 1.21 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-19.25
Price / Sales
0.00
Price / Book
-0.16
EV / EBITDA
2.01
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.06
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2001-10-22
Headquarters
Draper, UT, US
About SFLMaven Corp.

DNA Dynamics, Inc., operating through its subsidiaries, focuses on developing and distributing mobile applications and interactive entertainment for both smartphones and tablet devices. The company is proficient in creating and publishing games across Apple's iOS platform (including iPhone, iPad, and iPod touch) and Android, in addition to crafting various video games and applications for handheld consoles and other mobile devices. With a development footprint covering seven distinct platforms, DNA Dynamics also produces content for well-known television brands and intellectual property holders. The firm was founded in 1981 and maintains its corporate headquarters in Leamington Spa, United Kingdom.

Comparable companies

SFLMaven Corp. is most often compared with the following Healthcare names:

AOXGCBDLFFNTFGPFTJUVAFLRSVPEMTFPZOORLBDVDRM
More research on SFLM
SFLM technical analysis SFLM TheEdge Score Compare against peers
Open full interactive analysis & DCF →